Soluble urinary somatic angiotensin converting enzyme is overexpressed in patients with preeclampsia: a potential new marker for the disease?

Hypertens Pregnancy. 2022 Aug-Nov;41(3-4):190-197. doi: 10.1080/10641955.2022.2115060. Epub 2022 Aug 23.

Abstract

Objective: The aim of this study was to identify and quantify urinary Angiotensin-Converting-Enzyme (ACE) in hypertensive disorders of pregnancy.

Methods: Urine samples were analyzed by Western blot. Patients were classified into: normotensive pregnancy (N); preeclampsia and superimposed preeclampsia (PE+SPE); and gestational hypertension (GH).

Results: Somatic ACE protein expression was higher in PE+SPE compared to N and GH. There was a positive correlation between ACE and urinary protein to creatinine ratio, systolic and diastolic blood pressures.

Conclusion: These results indicate ACE overexpression in the urine of preeclamptic patients and suggest that it may be a new marker for the disease.

Keywords: Preeclampsia; angiotensin converting enzyme; hypertensive pregnancy disorder; renin angiotensin aldosterone system.

MeSH terms

  • Blood Pressure
  • Female
  • Humans
  • Hypertension*
  • Peptidyl-Dipeptidase A
  • Pre-Eclampsia*
  • Pregnancy
  • Renin-Angiotensin System

Substances

  • Peptidyl-Dipeptidase A